PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2019
Total Assets: $101.7K
Liabilities Breakdown FY2019
Total Liabilities: $4.4M
Asset Breakdown
Total Assets: $101.7K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.4K | 8.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $93.2K | 91.7% |
Liabilities Breakdown
Total Liabilities: $4.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $917.3K | 20.8% |
| Long-Term Debt | $1.7M | 37.6% |
| Other Liabilities | $1.8M | 41.5% |